Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China flag China · Delayed Price · Currency is CNY
11.74
+0.04 (0.34%)
Nov 6, 2026, 11:28 AM CST

SHA:688526 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
132.34176.8543.48581.74456.07555.36
Short-Term Investments
-664.39669.19451.14810547.35
Trading Asset Securities
1,6361,542719.51745.04674.83212.95
Cash & Short-Term Investments
1,7682,3831,9321,7781,9411,316
Cash Growth
2.70%23.36%8.68%-8.40%47.52%-39.76%
Accounts Receivable
284.55302.6354.81343.15406.52294.4
Other Receivables
5.44.324.8737.4734.9632.02
Receivables
289.95366.92359.69635.68441.48326.42
Inventory
132.02144.27125.6144.8169.4108.82
Other Current Assets
956.1832.4155.627.699.1210.42
Total Current Assets
3,1462,9272,4732,5662,5611,761
Property, Plant & Equipment
796.86877.95887.05858.9905.38904.15
Long-Term Investments
50.13907.161,0571,136799.2940.15
Goodwill
---3.313.31-
Other Intangible Assets
62.8465.7165.160.0359.9157.24
Long-Term Deferred Tax Assets
4.080.50.960.326.816.28
Long-Term Deferred Charges
1.121.121.61.18--
Other Long-Term Assets
516.649.710.9845.8835.1346.2
Total Assets
4,5784,7894,4964,6714,3913,725

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
125.66111.32178.26165.03244.27215.74
Accrued Expenses
38.4279.9287.6488.3692.7976.04
Short-Term Debt
---206.65131.618.03
Current Portion of Long-Term Debt
1.76--80.05-60.06
Current Portion of Leases
-1.611.351.060.65-
Current Income Taxes Payable
21.746.6930.7753.9831.0946.83
Current Unearned Revenue
174.39182.37148.6157.61101.763.18
Other Current Liabilities
41.6435.5816.875.5121.7412.35
Total Current Liabilities
403.57457.5463.5758.25623.84492.24
Long-Term Debt
----140.11-
Long-Term Leases
5.455.075.555.757.12-
Long-Term Unearned Revenue
65.4869.6666.0456.6261.7247.5
Long-Term Deferred Tax Liabilities
21.0117.7917.7112.9756.8429.68
Other Long-Term Liabilities
----1.991.99
Total Liabilities
495.5550.03552.8833.59891.63571.41

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
466.13466.13466.13466.17466.21465.13
Additional Paid-In Capital
1,1311,1271,1401,1411,1351,115
Retained Earnings
2,4872,6392,3872,2041,8971,576
Treasury Stock
-9-17.69-34.77-0.57-1.12-1.86
Comprehensive Income & Other
8.624.36-17.1425.33--
Total Common Equity
4,0834,2393,9413,8363,4973,153
Minority Interest
-1.190.42.052.032.070.44
Shareholders' Equity
4,0824,2393,9433,8383,4993,154
Total Liabilities & Equity
4,5784,7894,4964,6714,3913,725

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
7.26.686.9293.51279.4878.09
Net Cash (Debt)
1,7612,3771,9251,4841,6611,238
Net Cash Growth
2.69%23.45%29.70%-10.65%34.25%-41.73%
Net Cash Per Share
3.775.114.133.193.572.67
Filing Date Shares Outstanding
487.69453.53463.92464.69466.21465.13
Total Common Shares Outstanding
487.69453.53463.92466.17466.21465.13
Working Capital
2,7422,4702,0101,8081,9371,269
Book Value Per Share
8.379.358.498.237.506.78
Tangible Book Value
4,0204,1733,8763,7723,4343,096
Tangible Book Value Per Share
8.249.208.358.097.376.66
Buildings
-374.2291.93277.02270.37237.39
Machinery
-1,069974.9954.6942.59511.38
Construction In Progress
-33.5134.5143.0517388.72